To install click the Add extension button. That's it.

The source code for the WIKI 2 extension is being checked by specialists of the Mozilla Foundation, Google, and Apple. You could also do it yourself at any point in time.

4,5
Kelly Slayton
Congratulations on this excellent venture… what a great idea!
Alexander Grigorievskiy
I use WIKI 2 every day and almost forgot how the original Wikipedia looks like.
Live Statistics
English Articles
Improved in 24 Hours
Added in 24 Hours
Languages
Recent
Show all languages
What we do. Every page goes through several hundred of perfecting techniques; in live mode. Quite the same Wikipedia. Just better.
.
Leo
Newton
Brights
Milds

Synthon (company)

From Wikipedia, the free encyclopedia

Synthon
IndustryPharmaceutical
FoundedSeptember 17, 1991; 32 years ago (1991-09-17) in Nijmegen, Gelderland, The Netherlands
FounderDr. Jacques Lemmens
Headquarters,
Key people
CEO Anish Mehta
ProductsPharmaceutical
Number of employees
1,600 (2022)
Websitewww.synthon.com

Synthon is a Dutch multinational that produces generic human drugs.

The company was founded in 1991 by Jacques Lemmens and Marijn Oosterbaan, two organic chemists of the Radboud University Nijmegen. Synthon is active in the Netherlands, the Czech Republic, Spain, the United States, Argentina, Chile, Russia, Mexico and South Korea with about 1,500 employees. The company is headquartered in Nijmegen.

Medications made by Synthon include:

The products are marketed by partners of the company. The name Synthon is not mentioned on the packaging.

YouTube Encyclopedic

  • 1/3
    Views:
    1 899
    160 435
    16 220
  • 25.05 Synthons
  • SHIP Size Comparison (3D)
  • Synthons, Synthetic equivalents and Retrosynthetic analysis

Transcription

History

In 2007 the company started developing biopharmaceuticals.[3]

In May 2012 Synthon announced that it bought the Biolex LEX System for manufacturing biopharmaceuticals in Lemna. The sale also included two preclinical biologics made with the LEX System, BLX-301, a humanized and glyco-optimized anti-CD20 antibody for non-Hodgkin's B-cell lymphoma and other B-cell malignancies and BLX-155, a direct-acting thrombolytic. The financial terms of the sale were not disclosed.[4]

References

External links

This page was last edited on 23 April 2024, at 14:03
Basis of this page is in Wikipedia. Text is available under the CC BY-SA 3.0 Unported License. Non-text media are available under their specified licenses. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc. WIKI 2 is an independent company and has no affiliation with Wikimedia Foundation.